0001127602-21-014771.txt : 20210430 0001127602-21-014771.hdr.sgml : 20210430 20210430160827 ACCESSION NUMBER: 0001127602-21-014771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210428 FILED AS OF DATE: 20210430 DATE AS OF CHANGE: 20210430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NABEL ELIZABETH G CENTRAL INDEX KEY: 0001619929 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 21877962 MAIL ADDRESS: STREET 1: BRIGHAM AND WOMEN'S HOSPITAL STREET 2: 75 FRANCIS ST CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-04-28 0001682852 Moderna, Inc. MRNA 0001619929 NABEL ELIZABETH G C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Stock Option (Right to Buy) 178.68 2021-04-28 4 A 0 4081 0 A 2031-04-28 Common Stock 4081 4081 D Restricted Stock Units 0 2021-04-28 4 A 0 703 0 A Common Stock 703 703 D This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-04-30